Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Benke, Kálmán [VerfasserIn]   i
 Németh, Balázs Tamás [VerfasserIn]   i
 Sayour, Alex Ali [VerfasserIn]   i
 Stark, Klára Aliz [VerfasserIn]   i
 Oláh, Attila [VerfasserIn]   i
 Ruppert, Mihály [VerfasserIn]   i
 Szabó, Gábor [VerfasserIn]   i
 Korkmaz-İçöz, Sevil [VerfasserIn]   i
 Horváth, Eszter Mária [VerfasserIn]   i
 Benkő, Rita [VerfasserIn]   i
 Hartyánszky, István [VerfasserIn]   i
 Szabolcs, Zoltán [VerfasserIn]   i
 Merkely, Béla [VerfasserIn]   i
 Radovits, Tamás [VerfasserIn]   i
Titel:Stimulation of soluble guanylate cyclase improves donor organ function in rat heart transplantation
Verf.angabe:Kálmán Benke, Balázs Tamás Németh, Alex Ali Sayour, Klára Aliz Stark, Attila Oláh, Mihály Ruppert, Gábor Szabó, Sevil Korkmaz-Icöz, Eszter Mária Horváth, Rita Benkő, István Hartyánszky, Zoltán Szabolcs, Béla Merkely & Tamás Radovits
E-Jahr:2020
Jahr:24 March 2020
Umfang:9 S.
Fussnoten:Gesehen am 08.10.2020
Titel Quelle:Enthalten in: Scientific reports
Ort Quelle:[London] : Macmillan Publishers Limited, part of Springer Nature, 2011
Jahr Quelle:2020
Band/Heft Quelle:10(2020) Artikel-Nummer 5358, 9 Seiten
ISSN Quelle:2045-2322
Abstract:Heart transplantation remains the definitive therapy of end-stage heart failure. Ischemia-reperfusion injury occurring during transplantation is a primary determinant of long-term outcome of heart transplantation and primary graft insufficiency. Modification of the nitric oxide/soluble guanylate cyclase/cyclic guanosine monophosphate signaling pathway appears to be one of the most promising among the pharmacological interventional options. We aimed at characterizing the cardio-protective effects of the soluble guanylate cyclase stimulator riociguat in a rat model of heterotopic heart transplantation. Donor Lewis rats were treated orally with either riociguat or placebo for two days (n = 9) in each transplanted group and (n = 7) in donor groups. Following explantation, hearts were heterotopically transplanted. After one hour reperfusion, left ventricular pressure-volume relations and coronary blood flow were recorded. Molecular biological measurements and histological examination were also completed. Left ventricular contractility (systolic pressure: 117 ± 13 vs. 48 ± 5 mmHg, p < 0.001; dP/dtmax: 2963 ± 221 vs. 1653 ± 159 mmHg/s, p < 0.001), active relaxation (dP/dtmin: −2014 ± 305 vs. −1063 ± 177 mmHg/s, p = 0.02; all at 120 µl of left ventricular volume), and alteration of coronary blood flow standardized to heart weight (2.55 ± 0.32 vs. 1.67 ± 0.22 ml/min/g, p = 0.03) were markedly increased following preconditioning with riociguat. Myocardial apoptosis markers were also significantly reduced in the riociguat pretreated group as well as the antioxidant markers were elevated. Pharmacological preconditioning with riociguat decreases ischemia-reperfusion injury and improves donor organ function in our animal model of heart transplantation. Therefore, riociguat might be a potential cardioprotective agent.
DOI:doi:10.1038/s41598-020-62156-y
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: https://doi.org/10.1038/s41598-020-62156-y
 kostenfrei: Volltext: https://www.nature.com/articles/s41598-020-62156-y
 DOI: https://doi.org/10.1038/s41598-020-62156-y
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1735199303
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68646255   QR-Code
zum Seitenanfang